ConductScience.org, home

Paper20164024

The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.

Starska K and 6 others. Folia Histochem Cytobiol, 2009. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma. Papers, record 20164024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20164024

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.
PubMed
Journal
Folia Histochem Cytobiol
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2016-11-25
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Starska KKatarzyna
2Forma EEwa
3Lewy-Trenda IIwona
4Stasikowska OOlga
5Bryś MMagdalena
6Krajewska WMWanda M
7Łukomski MMarek

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Laryngeal NeoplasmsMajor topic
NF-kappa BMajor topic
Suppressor of Cytokine Signaling ProteinsMajor topic
Toll-Like Receptor 4Major topic
Aged
Aged, 80 and over
Biomarkers, Tumor
Disease Progression
Female
Humans
Immunohistochemistry
Interleukin-1 Receptor-Associated Kinases
Male
Middle Aged
Phenotype
RNA, Messenger
Reverse Transcriptase Polymerase Chain Reaction
Suppressor of Cytokine Signaling 1 Protein
TNF Receptor-Associated Factor 6

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42121921Interplay Between TLR4 and Gelatinases in Tumour Growth and Metastasis.Cells2026https://conductscience.org/library/papers/42121921PubMed
40347321Inhibition of SIRT1/HSF1 pathway contributes to doxorubicin-induced nephrotoxicity in ovarian tumor-bearing mice.Apoptosis2025https://conductscience.org/library/papers/40347321PubMed
35116557Up-regulation of SOCS4 promotes cell proliferation and migration in esophageal squamous cell carcinoma.Transl Cancer Res2021https://conductscience.org/library/papers/35116557PubMed
31318878Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry.PLoS One2019https://conductscience.org/library/papers/31318878PubMed
29051178TLR4-Mediated Inflammation Promotes KSHV-Induced Cellular Transformation and Tumorigenesis by Activating the STAT3 Pathway.Cancer Res2017https://conductscience.org/library/papers/29051178PubMed
27538408Ischemic Preconditioning-Induced SOCS-1 Protects Rat Intestinal Ischemia Reperfusion Injury via Degradation of TRAF6.Dig Dis Sci2017https://conductscience.org/library/papers/27538408PubMed
25973756Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice.PLoS One2015https://conductscience.org/library/papers/25973756PubMed
24235843Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers.Onco Targets Ther2013https://conductscience.org/library/papers/24235843PubMed
24127926Different cellular localization of NF-κB p65 expression as an indicator of different prognoses of stage I-III gastric cancer patients.Clin Transl Sci2013https://conductscience.org/library/papers/24127926PubMed
23437123Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3.PLoS One2013https://conductscience.org/library/papers/23437123PubMed
22736025TNF receptor-associated factor 6 in advanced non-small cell lung cancer: clinical and prognostic implications.J Cancer Res Clin Oncol2012https://conductscience.org/library/papers/22736025PubMed
22110526Toll-like receptor 4 activation in cancer progression and therapy.Clin Dev Immunol2011https://conductscience.org/library/papers/22110526PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IRAK13654PubTator's text mininghttps://conductscience.org/library/genes/3654NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
RELA5970PubTator's text mininghttps://conductscience.org/library/genes/5970NCBI Gene
SOCS18651PubTator's text mininghttps://conductscience.org/library/genes/8651NCBI Gene
TFG10342PubTator's text mininghttps://conductscience.org/library/genes/10342NCBI Gene
TLR47099PubTator's text mininghttps://conductscience.org/library/genes/7099NCBI Gene
TRAF67189PubTator's text mininghttps://conductscience.org/library/genes/7189NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20164024

GET https://conductscience.org/api/papers/v1/20164024/authors